Iqvia Holdings (IQV) Cash from Financing Activities (2012 - 2026)
Iqvia Holdings (IQV) posted Cash from Financing Activities of -$433.0 million for Q1 2026, down 180.93% sequentially from $535.0 million in Q4 2025, and down 67.83% YoY from -$1.3 billion in Q1 2025.
Iqvia Holdings (IQV) Cash from Financing Activities (2012 - 2026) Analysis & Trends
Iqvia Holdings (IQV) has 15 years of Cash from Financing Activities data on file, last reported at -$433.0 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 67.83% year-over-year to -$433.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$325.0 million (up 68.45% YoY) and the FY2025 annual result came in at -$150.0 million, up 82.92% from the prior year.
- Cash from Financing Activities slipped to -$433.0 million in Q1 2026 per IQV's latest filing, from $535.0 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $535.0 million in Q4 2025, with the low at -$572.0 million in Q3 2025.
- Average Cash from Financing Activities over 5 years is -$127.8 million, with a median of -$144.0 million recorded in 2023.
- Year-over-year, Cash from Financing Activities surged 427.59% in 2023 and tumbled 373.68% in 2024.
- Iqvia Holdings' Cash from Financing Activities stood at -$193.0 million in 2022, then plunged by 117.62% to -$420.0 million in 2023, then gained by 10.71% to -$375.0 million in 2024, then jumped by 242.67% to $535.0 million in 2025, then slumped by 180.93% to -$433.0 million in 2026.
- Business Quant data shows IQV's Cash from Financing Activities at -$433.0 million in Q1 2026, $535.0 million in Q4 2025, and -$572.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 3.76 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -144.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Quest Diagnostics | 23.76 Bn | 23.67 Bn | 942.00 Mn | -152.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -433.00 Mn |
| Mar 31, 2026 | -433.00 Mn |
| Dec 31, 2025 | 535.00 Mn |
| Dec 31, 2025 | 535.00 Mn |
| Sep 30, 2025 | -572.00 Mn |
| Sep 30, 2025 | -572.00 Mn |
| Jun 30, 2025 | 145.00 Mn |
| Jun 30, 2025 | 145.00 Mn |
| Mar 31, 2025 | -258.00 Mn |
| Mar 31, 2025 | -258.00 Mn |
| Dec 31, 2024 | -375.00 Mn |
| Dec 31, 2024 | -375.00 Mn |
| Sep 30, 2024 | -137.00 Mn |
| Sep 30, 2024 | -137.00 Mn |
| Jun 30, 2024 | -260.00 Mn |
| Jun 30, 2024 | -260.00 Mn |
| Mar 31, 2024 | -106.00 Mn |
| Mar 31, 2024 | -106.00 Mn |
| Dec 31, 2023 | -420.00 Mn |
| Dec 31, 2023 | -420.00 Mn |